RTX · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $88.60B | $80.74B | $68.92B | $67.07B | $64.39B | $56.59B | $45.35B | $34.70B |
| Research & Development | $2.81B | $2.93B | $2.81B | $2.71B | $2.73B | $2.58B | $2.45B | $1.88B |
| Selling, General & Administrative | $6.09B | $5.81B | $5.81B | $5.57B | $5.05B | $5.54B | $3.71B | $2.86B |
| Operating Expenses | $79.72B | $74.07B | $65.44B | $61.69B | $59.67B | $56.18B | $40.76B | $32.21B |
| Operating Income | $9.30B | $6.54B | $3.56B | $5.50B | $5.14B | -$1.89B | $4.91B | $2.88B |
| Interest Expense | — | $1.86B | $1.50B | $1.28B | $1.32B | $1.37B | $1.59B | $1.03B |
| Other Income / (Expense) | -$567.00M | -$344.00M | $275.00M | -$613.00M | $27.00M | $464.00M | $762.00M | $373.00M |
| Income Before Taxes | $8.73B | $6.19B | $3.84B | $6.12B | $5.11B | -$2.35B | $4.15B | $2.50B |
| Provision for Income Taxes | $1.66B | $1.18B | $456.00M | $790.00M | $964.00M | $575.00M | $421.00M | $1.10B |
| Net Income | $6.73B | $4.77B | $3.19B | $5.20B | $3.86B | -$3.52B | $5.54B | $5.27B |
| Basic EPS | $5.02 | $3.58 | $2.24 | $3.52 | $2.57 | -$2.59 | $6.48 | $6.58 |
| Diluted EPS | $4.96 | $3.55 | $2.23 | $3.50 | $2.56 | -$2.59 | $6.41 | $6.50 |
| Basic Shares Outstanding | 1.34B | 1.33B | 1.43B | 1.48B | 1.50B | 1.36B | 854.80M | 800.40M |
| Diluted Shares Outstanding | 1.36B | 1.34B | 1.44B | 1.49B | 1.51B | 1.36B | 863.90M | 810.10M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $7.21 | $7.15 | $7.30 | 8 | ↑8 ↓0 |
| Dec 2027 | $7.76 | $7.33 | $7.97 | 8 | ↑8 ↓0 |
| Dec 2028 | $8.30 | $7.42 | $8.86 | 4 | ↑4 ↓0 |
| Dec 2029 | $8.83 | $7.92 | $9.75 | 2 | ↑2 ↓0 |